These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1970586)

  • 1. A metaanalysis of controlled trials of neuroleptic treatment in dementia.
    Schneider LS; Pollock VE; Lyness SA
    J Am Geriatr Soc; 1990 May; 38(5):553-63. PubMed ID: 1970586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic treatment of agitation and psychosis in dementia.
    Devanand DP; Levy SR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S18-27. PubMed ID: 8561840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2002; (2):CD002852. PubMed ID: 12076456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agitation in nursing home residents with dementia (VIDEANT trial): effects of a cluster-randomized, controlled, guideline implementation trial.
    Rapp MA; Mell T; Majic T; Treusch Y; Nordheim J; Niemann-Mirmehdi M; Gutzmann H; Heinz A
    J Am Med Dir Assoc; 2013 Sep; 14(9):690-5. PubMed ID: 23827658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.
    Lanctôt KL; Best TS; Mittmann N; Liu BA; Oh PI; Einarson TR; Naranjo CA
    J Clin Psychiatry; 1998 Oct; 59(10):550-61; quiz 562-3. PubMed ID: 9818639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the elderly agitated patient.
    Salzman C
    J Clin Psychiatry; 1987 May; 48 Suppl():19-22. PubMed ID: 2883176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.
    Meehan KM; Wang H; David SR; Nisivoccia JR; Jones B; Beasley CM; Feldman PD; Mintzer JE; Beckett LM; Breier A
    Neuropsychopharmacology; 2002 Apr; 26(4):494-504. PubMed ID: 11927174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life.
    Bascom PB; Bordley JL; Lawton AJ
    Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological treatment of agitation in a nursing home.
    Billig N; Cohen-Mansfield J; Lipson S
    J Am Geriatr Soc; 1991 Oct; 39(10):1002-5. PubMed ID: 1680888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.
    Franco KN; Messinger-Rapport B
    J Am Med Dir Assoc; 2006 Mar; 7(3):201-2. PubMed ID: 16503315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.